Skip to content

SPD2 – The shortage pandemic – why we haven’t succeeded yet

Room:

Auditorium VI

Facilitator:

Gunar Stemer

Speakers:

Abstract:

 

Link to EAHP Statements

  • Section 2 – Selection, Procurement and Distribution: Statements – 2.2, 2.5, 2.6

ACPE UAN: 0475-0000-23-012-L04-P – A knowledge-based activity

Abstract

After many years the occurrence of medicines shortages still constitutes a steady challenge for hospital pharmacists in terms of various shortages’ management aspects. For example, when it comes to suggesting and sourcing therapeutic alternatives and accompanying the transition of medicines in various setting with expertise, information and education. If applied mitigation strategies fail, this challenge expands and escalates to other healthcare professionals and patients. The availability of therapeutically equivalent therapeutic options is considered a best-case scenario, whereas lack of adequate alternatives and resulting consequences (e.g. therapeutic delays) can be seen as a worst-case scenario. 

In the past years, several different initiatives and projects, involving different stakeholders and other parties, were established, investigating causes and developing counteracting measures. Research on medicines shortages is conducted, as illustrated by many publications on various management aspects. On a political level, the problem of shortages is accepted as an essential and important one.

In 2020, the COVID-19 pandemic dramatically proved how fragile and susceptible supply chains of medicines still are and how quickly apparently stable situations can aggravate. After all achievements in the context of medicines shortages’ management prior to COVID-19, enormous efforts are still needed to counteract shortages and stabilise drug supply sustainably. Is it realistic to consider shortages an unsolvable problem? Did shortages come to stay?

Learning objectives

After the session, the participant should be able to:   

  • Repeat key facts about current epidemiology and aetiology of medicines shortages
  • Recall up-to-date and actual initiatives on an European and global level to address shortages and discuss various strategies against it
  • State key learnings from the COVID-19 pandemic in the context of shortages management, both on a practice and political level

Educational need addressed

Hospital pharmacists are responsible for providing the right medicines to patients and therefore essentially rely on trusted availability of medicines. Extensive state-of-the-art knowledge on medicines shortages and all relating activities is key to fulfil this core responsibility of hospital pharmacy. 

Keywords: Medicines shortages, pandemic, counteracting strategies

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.